Article
Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence.
Expert opinion on pharmacotherapy - 1 Feb 2024
Watkins Lance V, Moon Seungyoun, Burrows Lisa, Tromans Samuel, Barwell Julian, Shankar Rohit
Abstract excerpt
INTRODUCTION: Fragile X syndrome (FXS) is the most common inherited cause of Intellectual Disability. There is a broad phenotype that includes deficits in cognition and behavioral changes, alongside physical characteristics. Phenotype depends upon the level of mutation in the FMR1 (fragile X messenger ribonucleoprotein 1) gene. The molecular understanding of the impact of the FMR1 gene mutation provides an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
